Arrowhead Pharma (ARWR)

$82.15 0.00 (0.00%)

18:53 EST ARWR Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 7.19B

PE Ratio -144.12

EPS -0.57

Volume (Avg. Vol.)

Day's Range 82.15 - 82.15

52-Week Range 19.51 - 86.75

Dividend & Yield N/A (N/A)

ARWR Stock Predictions, Articles, and Arrowhead Pharma News

From InvestorPlace
From the Web

7 Nanotech Stocks To Buy With Huge Returns in Store

By Chris Lau, InvestorPlace Contributor Dec 30, 2020

Seven nanotech stocks to buy have the potential to reward investors as innovation in the sector accelerates.

Arrowhead Pharmaceuticals News: Why ARWR Stock Is Shooting 45% Higher Today

By William White, InvestorPlace Writer Sep 16, 2020

Arrowhead Pharmaceuticals (ARWR) news for Wednesday includes positive interim results from a clinical trial pushing ARWR stock higher.

3 Biotech Stocks to Bank on for Buyouts in 2020

By Aaron Levitt, InvestorPlace Contributor Jan 10, 2020

Flushed with cash, bigger biotech stocks are on the hunt. These 3 smaller drug makers could be the next buyout targets in the new year.

7 Exciting Biotech Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor Dec 2, 2019

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

7 Top-Rated Biotech Stocks to Invest In Today

By Louis Navellier, Editor, Growth Investor Jun 14, 2019

Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.

5 Hot Small-Cap Stocks That Are a Bit Too Toasty

By Josh Enomoto, InvestorPlace Contributor Jan 22, 2019

These small-cap stocks may have triggered your radar, but recently, they have become way too hot to handle.

ARWR Stock Sinks After Signing a Big Collaboration Deal

By Chris Lau, InvestorPlace Contributor Oct 9, 2018

ARWR stock fell big after signing a great collaboration agreement with a JNJ unit. The markets are overreacting.

Arrowhead Stock Is Not Done Rallying After Its 38% Jump

By Chris Lau, InvestorPlace Contributor Sep 7, 2018

Yesterday, Arrowhead's clinical data results excited shareholders, but ARWR stock still has plenty of upside ahead.

3 Stocks to Watch on Wednesday: Arrowhead Pharmaceuticals Inc (ARWR), VeriFone Systems Inc (PAY) and Streamline Health Solutions Inc. (STRM)

By Karl Utermohlen, InvestorPlace Writer Dec 13, 2017

Arrowhead Pharmaceuticals (ARWR), VeriFone Systems (PAY) and Streamline Health Solutions (STRM) posted their earnings results late Tuesday.

First Week of September 17th Options Trading For Arrowhead Pharmaceuticals (ARWR)

From Market News Video Jan 19, 2021

Investors in Arrowhead Pharmaceuticals Inc (ARWR) saw new options become available this week, for the September 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Technical Short Put Spread Fade the Dip Trade and Trigger in Arrowhead Pharmaceuticals Inc

From Capital Market Laboratories Jan 1, 2021

The Techncial Trigger Driven Option Trade Right Before Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Earnings.

First Week of February 2021 Options Trading For Arrowhead Pharmaceuticals (ARWR)

From Market News Video Dec 22, 2020

Investors in Arrowhead Pharmaceuticals Inc (ARWR) saw new options become available this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARWR options chain for the new February 2021 contracts and identified one put and one call contract of particular interest.

Navellier Ratings

Total Grade

Hold

Arrowhead Pharma (ARWR)

ARWR Stock Predictions, Articles, and Arrowhead Pharma News

Navellier Ratings

Total Grade

Subscriber Sign in